婴儿细菌性脑膜炎的流行病学、治疗与结局
该队列研究纳入加拿大7家儿科三级医院2013至2014年收治的113例小于90日龄细菌性脑膜炎患儿,主要病原为大肠埃希菌(33%)和B组链球菌(31%),74%患儿留有后遗症,7%死亡;经验性治疗应考虑三代头孢菌素(至少第一个月加用氨苄西林),若为革兰阴性脑膜炎可用碳青霉烯类替代头孢菌素。
要点
- 大肠埃希菌和B组链球菌仍是小于90日龄婴儿细菌性脑膜炎最常见病原。
- 经验性治疗用三代头孢菌素,至少第一个月加用氨苄西林。
- 若证实革兰阴性脑膜炎,可考虑用碳青霉烯类替代头孢菌素。
核心结论
- 大肠埃希菌和B组链球菌仍是出生后90天内细菌性脑膜炎最常见病原。
- 疑似细菌性脑膜炎的经验性治疗应考虑三代头孢菌素,至少第一个月加用氨苄西林。
- 若有革兰阴性脑膜炎证据,可考虑用碳青霉烯类替代头孢菌素。
研究设计与样本
- 该研究为队列研究,纳入加拿大7家儿科三级医院2013至2014年收治的113例小于90日龄细菌性脑膜炎患儿。
主要发现
- 113例中确诊脑膜炎63例、疑似脑膜炎50例,就诊年龄中位数19天,63例(56%)从家中就诊时即诊断。
- 主要病原为大肠埃希菌37例(33%)和B组链球菌35例(31%)。
- 第0至6天就诊的15例脑膜炎患儿中,2例分离株对氨苄西林和庆大霉素均耐药(大肠埃希菌和B型流感嗜血杆菌)。
- 第7至90天从家中就诊的60例脑膜炎患儿中,6例分离株对头孢噻肟不是好选择(产单核细胞李斯特菌3例、阴沟肠杆菌、阪崎克罗诺杆菌和施氏假单胞菌)。
- 84例(74%)记录有后遗症,包括8例死亡(7%)。
关键数值与推荐
- 疑似细菌性脑膜炎经验性治疗:考虑三代头孢菌素,至少第一个月加用氨苄西林。
- 若有革兰阴性脑膜炎证据,可考虑用碳青霉烯类替代头孢菌素。
临床怎么用
- 小于90日龄婴儿疑似细菌性脑膜炎时,经验性用药应覆盖大肠埃希菌和B组链球菌,并考虑三代头孢菌素加氨苄西林(至少第一个月)。
- 若脑脊液革兰染色或培养提示革兰阴性菌,可考虑用碳青霉烯类替代头孢菌素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The pathogens that cause bacterial meningitis in infants and their antimicrobial susceptibilities may have changed in this era of increasing antimicrobial resistance, use of conjugated vaccines, and maternal antibiotic prophylaxis for group B Streptococcus (GBS). The objective was to determine the optimal empirical antibiotics for bacterial meningitis in early infancy. METHODS: This was a cohort study of infants <90 days of age with bacterial meningitis at 7 pediatric tertiary care hospitals across Canada in 2013 and 2014. RESULTS: There were 113 patients diagnosed with proven meningitis (n = 63) or suspected meningitis (n = 50) presented at median 19 days of age, with 63 patients (56%) presenting a diagnosis from home. Predominant pathogens were Escherichia coli (n = 37; 33%) and GBS (n = 35; 31%). Two of 15 patients presenting meningitis on day 0 to 6 had isolates resistant to both ampicillin and gentamicin (E coli and Haemophilus influenzae type B). Six of 60 infants presenting a diagnosis of meningitis from home from day 7 to 90 had isolates, for which cefotaxime would be a poor choice (Listeria monocytogenes [n = 3], Enterobacter cloacae, Cronobacter sakazakii, and Pseudomonas stutzeri). Sequelae were documented in 84 infants (74%), including 8 deaths (7%). CONCLUSIONS: E coli and GBS remain the most common causes of bacterial meningitis in the first 90 days of life. For empirical therapy of suspected bacterial meningitis, one should consider a third-generation cephalosporin (plus ampicillin for at least the first month), potentially substituting a carbapenem for the cephalosporin if there is evidence for Gram-negative meningitis.
引用
- Ouchenir L, Renaud C, Khan S, et al. The Epidemiology, Management, and Outcomes of Bacterial Meningitis in Infants. Pediatrics. 2017. PMID: 28600447. doi:10.1542/peds.2017-0476
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。